NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 230 filers reported holding NEKTAR THERAPEUTICS in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $22,000 | +144.4% | 4,078 | +537.2% | 0.02% | +53.8% |
| Q4 2021 | $9,000 | -62.5% | 640 | -37.1% | 0.01% | -53.6% |
| Q3 2021 | $24,000 | -69.6% | 1,017 | -78.1% | 0.03% | -68.2% |
| Q4 2020 | $79,000 | +229.2% | 4,639 | +356.1% | 0.09% | +877.8% |
| Q2 2020 | $24,000 | -42.9% | 1,017 | -56.9% | 0.01% | -86.8% |
| Q1 2020 | $42,000 | -93.3% | 2,357 | -87.7% | 0.07% | -86.2% |
| Q4 2018 | $628,000 | – | 19,113 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |